Literature DB >> 20109017

Antibiotic modification of native grafts: improving upon nature's scaffolds.

Constantinos Ketonis1, Christopher S Adams, Stephanie Barr, Amiethab Aiyer, Irving M Shapiro, Javad Parvizi, Noreen J Hickok.   

Abstract

Infection associated with inert implants is complicated by bacterial biofilm formation that renders the infection antibiotic insensitive. The goal of this investigation was to synthesize and characterize a vancomycin (VAN)-modified bone allograft that could render the tissue inhospitable to bacterial colonization and the establishment of infection. We found that the numbers of primary amines, which could serve as anchors for chemical synthesis, increased with limited demineralization. Using these amines, we coupled two linkers and VAN to bone using Fmoc chemistry. By immunohistochemistry, VAN was abundant on the surface of the allograft; based on elution and measurement of bound antibody, this coupling yielded at least approximately 26 ng VAN/mg bone. The coupled VAN appeared to be permanently bound to the allograft, as it showed no elution in a disk diffusion assay, and, importantly, resisted colonization by Staphylococcus aureus challenges. We suggest that this chimeric construct represents a new generation of antibiotic-modified allografts that provide antibacterial properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109017      PMCID: PMC2949234          DOI: 10.1089/ten.TEA.2009.0610

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  29 in total

Review 1.  Allograft bone. The influence of processing on safety and performance.

Authors:  T Boyce; J Edwards; N Scarborough
Journal:  Orthop Clin North Am       Date:  1999-10       Impact factor: 2.472

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

3.  Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents.

Authors:  M Souli; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Infection in total knee replacement: a retrospective review of 6489 total knee replacements.

Authors:  G Peersman; R Laskin; J Davis; M Peterson
Journal:  Clin Orthop Relat Res       Date:  2001-11       Impact factor: 4.176

5.  Infection in bone allografts. Incidence, nature, and treatment.

Authors:  C F Lord; M C Gebhardt; W W Tomford; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1988-03       Impact factor: 5.284

6.  Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use.

Authors:  W W Tomford; J Thongphasuk; H J Mankin; M J Ferraro
Journal:  J Bone Joint Surg Am       Date:  1990-09       Impact factor: 5.284

Review 7.  Molecular biology of matrix vesicles.

Authors:  H C Anderson
Journal:  Clin Orthop Relat Res       Date:  1995-05       Impact factor: 4.176

Review 8.  The structural biology of molecular recognition by vancomycin.

Authors:  P J Loll; P H Axelsen
Journal:  Annu Rev Biophys Biomol Struct       Date:  2000

9.  Proximal femoral allografts for reconstruction of bone stock in revision arthroplasty of the hip.

Authors:  A E Gross; C R Hutchison; M Alexeeff; N Mahomed; K Leitch; E Morsi
Journal:  Clin Orthop Relat Res       Date:  1995-10       Impact factor: 4.176

Review 10.  Clinical use of bone allografts.

Authors:  H T Aro; A J Aho
Journal:  Ann Med       Date:  1993-08       Impact factor: 4.709

View more
  10 in total

1.  Antibacterial activity of bone allografts: comparison of a new vancomycin-tethered allograft with allograft loaded with adsorbed vancomycin.

Authors:  Constantinos Ketonis; Stephanie Barr; Irving M Shapiro; Javad Parvizi; Christopher S Adams; Noreen J Hickok
Journal:  Bone       Date:  2010-10-28       Impact factor: 4.398

2.  Vancomycin bonded to bone grafts prevents bacterial colonization.

Authors:  Constantinos Ketonis; Stephanie Barr; Christopher S Adams; Irving M Shapiro; Javad Parvizi; Noreen J Hickok
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

3.  Polymer-controlled release of tobramycin from bone graft void filler.

Authors:  Amanda E Brooks; Benjamin D Brooks; Sherry N Davidoff; Paul C Hogrebe; Mark A Fisher; David W Grainger
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 4.  Molecular engineering of an orthopaedic implant: from bench to bedside.

Authors:  I M Shapiro; N J Hickok; J Parvizi; S Stewart; T P Schaer
Journal:  Eur Cell Mater       Date:  2012-05-24       Impact factor: 3.942

Review 5.  [Use of antibiotics in bones : Prophylaxis and current treatment standards].

Authors:  L Frommelt
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

Review 6.  Immobilized antibiotics to prevent orthopaedic implant infections.

Authors:  Noreen J Hickok; Irving M Shapiro
Journal:  Adv Drug Deliv Rev       Date:  2012-04-04       Impact factor: 15.470

7.  Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro.

Authors:  A H Nguyen; S Kim; W J Maloney; J C Wenke; Y Yang
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

8.  Antibiotic-impregnated bone grafts in orthopaedic and trauma surgery: a systematic review of the literature.

Authors:  Konstantinos Anagnostakos; Katrin Schröder
Journal:  Int J Biomater       Date:  2012-07-26

Review 9.  Role of Implantable Drug Delivery Devices with Dual Platform Capabilities in the Prevention and Treatment of Bacterial Osteomyelitis.

Authors:  Caroline Billings; David E Anderson
Journal:  Bioengineering (Basel)       Date:  2022-02-06

Review 10.  Development of Silver-Containing Hydroxyapatite-Coated Antimicrobial Implants for Orthopaedic and Spinal Surgery.

Authors:  Tadatsugu Morimoto; Hirohito Hirata; Shuichi Eto; Akira Hashimoto; Sakumo Kii; Takaomi Kobayashi; Masatsugu Tsukamoto; Tomohito Yoshihara; Yu Toda; Masaaki Mawatari
Journal:  Medicina (Kaunas)       Date:  2022-04-06       Impact factor: 2.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.